Basic information about inhibitors

IPAD-DB ID	S00138
Name	N-(2-(4-Benzhydrylpiperazin-1-yl)ethyl)-1-benzylpyrrolidin-3-amine
Category	Synthetic compounds
2D Structure
3D Structure
Molecular Formula	C 3 0 H 3 8 N 4
Molecular Weight	454.6 g/mol
IUPAC Name	N-[2-(4-benzhydrylpiperazin-1-yl)ethyl]-1-benzylpyrrolidin-3-amine
InChI	InChI=1S/C30H38N4/c1-4-10-26(11-5-1)24-33-18-16-29(25-33)31-17-19-32-20-22-34(23-21-32)30(27-12-6-2-7-13-27)28-14-8-3-9-15-28/h1-15, 29-31H, 16-25H2
InChIKey	BSXHVZJBZDQZMH-UHFFFAOYSA-N
Canonical SMILES	C1CN(CC1NCCN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)CC5=CC=CC=C5
PubChem CID	155566097
DrugBank Accession Number	-
CAS Registry Number	-

Biological activity data

Ki	-
EC50
IC50
Inhibition	27.6% ± 1.0(eeAChE%), 46.2% ± 1.1(eqBCHE% ), 34.2% ± 9.4(hBACE1%), 31.6% ± 3.8 (In cellulo Aβ42 inhibition %), 64.0% ± 4.6(In cellulo tau inhibition %),
Toxicity
ROS(reactive oxygen species)
Metal Chelating	Cu2+
BBB(blood-brain barrier)
Target Protein	Tau protein
Effects
Research Models	Escherichia coli, molecular docking , in vitro, in Bacterial Cells,
Ref. Link

Physicochemical properties

Molecular Weight(Computed by SwissADME)	454.65
Hac(Computed by SwissADME)	34
Volume(Computed by ADMETlab 2.0)	504.913
Density(Computed by ADMETlab 2.0)	0.9
nRing(Computed by ADMETlab 2.0)	5
MaxRing(Computed by ADMETlab 2.0)	6
nHet(Computed by ADMETlab 2.0)	4
fChar(Computed by ADMETlab 2.0)	0
nRig(Computed by ADMETlab 2.0)	29
Flexibility(Computed by ADMETlab 2.0)	0.31
Stero Centers(Computed by ADMETlab 2.0)	1
LogS(Computed by ADMETlab 2.0)	-2.326
LogD(Computed by ADMETlab 2.0)	4.044

ADMET properties

logP(Computed by ADMETlab 2.0)	4.079
TPSA(Computed by SwissADME)	21.75
Hbond Acceptor(Computed by SwissADME)	4
Hbond Donor(Computed by SwissADME)	1
Rotatable Bonds(Computed by SwissADME)	9

Pharmacokinetics

GI Absorption(Computed by SwissADME)	High
BBB(blood-brain barrier) Permeant(Computed by SwissADME)	Yes
P-gp Substrate(Computed by SwissADME)	Yes
CYP1A2 Inhibitor(Computed by SwissADME)	No
CYP2C19 Inhibitor(Computed by SwissADME)	No
CYP2C9 Inhibitor(Computed by SwissADME)	No
CYP2D6 Inhibitor(Computed by SwissADME)	Yes
CYP3A4 Inhibitor(Computed by SwissADME)	No
log Kp(Skin Permeation)(Computed by SwissADME)	-5.84

Druglikeness

Lipinski(Computed by SwissADME)	0
Ghose(Computed by SwissADME)	2
Veber(Computed by SwissADME)	0
Egan(Computed by SwissADME)	0
Muegge(Computed by SwissADME)	0
Bioavailability Score(Computed by SwissADME)	0.55